Local Advanced or Metastatic NSCLC
1 competing product in clinical development for Local Advanced or Metastatic NSCLC.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Garsorasib, Benmelstobart, Anlotinib + Benmelstobart, Anlotinib + Garsorasib, Cetuximab Beta Injection | Sun Pharmaceutical | Phase 2 | Recruiting | 42 |